James A. Dykens

5.7k total citations
50 papers, 4.4k citations indexed

About

James A. Dykens is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, James A. Dykens has authored 50 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Genetics and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in James A. Dykens's work include Estrogen and related hormone effects (13 papers), Menopause: Health Impacts and Treatments (12 papers) and Mitochondrial Function and Pathology (11 papers). James A. Dykens is often cited by papers focused on Estrogen and related hormone effects (13 papers), Menopause: Health Impacts and Treatments (12 papers) and Mitochondrial Function and Pathology (11 papers). James A. Dykens collaborates with scholars based in United States, United Kingdom and Russia. James A. Dykens's co-authors include Yvonne Will, J. Malcolm Shick, James W. Simpkins, Lisa D. Marroquin, Arnold Stern, James T. Hynes, James D. Jamieson, Sashi Nadanaciva, Ekkhart Trenkner and Joseph Jamieson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

James A. Dykens

50 papers receiving 4.3k citations

Peers

James A. Dykens
Philip Cohen United Kingdom
Carol MacKintosh United Kingdom
George G. Holz United States
James A. Dykens
Citations per year, relative to James A. Dykens James A. Dykens (= 1×) peers Carlo Storelli

Countries citing papers authored by James A. Dykens

Since Specialization
Citations

This map shows the geographic impact of James A. Dykens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Dykens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Dykens more than expected).

Fields of papers citing papers by James A. Dykens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Dykens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Dykens. The network helps show where James A. Dykens may publish in the future.

Co-authorship network of co-authors of James A. Dykens

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Dykens. A scholar is included among the top collaborators of James A. Dykens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Dykens. James A. Dykens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moos, Walter H., James A. Dykens, Dana Nohynek, Evelina Rubinchik, & Neil Howell. (2009). Review of the effects of 17α‐estradiol in humans: a less feminizing estrogen with neuroprotective potential. Drug Development Research. 70(1). 1–21. 25 indexed citations
2.
Greene, Nigel, et al.. (2009). A current practice for predicting ocular toxicity of systemically delivered drugs. Cutaneous and Ocular Toxicology. 28(1). 1–18. 12 indexed citations
3.
Dykens, James A., Joseph Jamieson, Lisa D. Marroquin, et al.. (2008). In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone. Toxicological Sciences. 103(2). 335–345. 149 indexed citations
4.
Dykens, James A., et al.. (2008). Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicology and Applied Pharmacology. 233(2). 203–210. 174 indexed citations
5.
Will, Yvonne, James A. Dykens, Sashi Nadanaciva, et al.. (2008). Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells. Toxicological Sciences. 106(1). 153–161. 171 indexed citations
6.
Marroquin, Lisa D., James T. Hynes, James A. Dykens, James D. Jamieson, & Yvonne Will. (2007). Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants. Toxicological Sciences. 97(2). 539–547. 464 indexed citations
7.
Dykens, James A. & Yvonne Will. (2007). The significance of mitochondrial toxicity testing in drug development. Drug Discovery Today. 12(17-18). 777–785. 303 indexed citations
8.
Dykens, James A., Lisa D. Marroquin, & Yvonne Will. (2007). Strategies to reduce late-stage drug attrition due to mitochondrial toxicity. Expert Review of Molecular Diagnostics. 7(2). 161–175. 76 indexed citations
9.
Simpkins, James W. & James A. Dykens. (2007). Mitochondrial mechanisms of estrogen neuroprotection. Brain Research Reviews. 57(2). 421–430. 108 indexed citations
10.
Wang, Xiaofei, James A. Dykens, Evelyn Perez, et al.. (2006). Neuroprotective Effects of 17β-Estradiol and Nonfeminizing Estrogens against H2O2 Toxicity in Human Neuroblastoma SK-N-SH Cells. Molecular Pharmacology. 70(1). 395–404. 79 indexed citations
11.
Simpkins, James, Jian Wang, Xiaofei Wang, et al.. (2005). Mitochondria Play a Central Role in Estrogen-Induced Neuroprotection. PubMed. 4(1). 69–83. 96 indexed citations
12.
Dykens, James A., Walter H. Moos, & Neil Howell. (2005). Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study. Annals of the New York Academy of Sciences. 1052(1). 116–135. 60 indexed citations
13.
Dykens, James A., Sandra E. Wiley, Douglas F. Covey, et al.. (2004). Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog. Biochemical Pharmacology. 68(10). 1971–1984. 28 indexed citations
14.
Dykens, James A.. (2003). Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism. Experimental Gerontology. 38(1-2). 101–107. 35 indexed citations
15.
Dykens, James A., et al.. (2002). High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer. Mitochondrion. 1(5). 461–473. 13 indexed citations
16.
Johnson, Kristen, A. Jung, Anne N. Murphy, et al.. (2000). Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis & Rheumatism. 43(7). 1560–1570. 165 indexed citations
17.
Schimmer, Ralph C., Denis J. Schrier, Craig M. Flory, et al.. (1997). Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. The Journal of Immunology. 159(8). 4103–4108. 41 indexed citations
18.
19.
Shick, J. Malcolm & James A. Dykens. (1985). Oxygen detoxification in algal-invertebrate symbioses from the Great Barrier Reef. Oecologia. 66(1). 33–41. 65 indexed citations
20.
Dykens, James A., Charlotte P. Mangum, & John M. Arnold. (1982). A Note on the Structural Organization of the Cardiac Myofiber in Nautilus pompilius. ScholarSpace (University of Hawaii at Manoa). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026